Pandion Therapeutics

Bambusa Therapeutics

The company develops bispecific antibodies for patients with immunological and inflammatory disorders.

Reverb Therapeutics

This biotechnology company develops bispecific antibody therapies that redirect the body's natural cytokines to treat patients with cancer and autoimmune diseases.

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

Attovia Therapeutics

The company develops biparatopic biologics to treat patients with immune-mediated diseases and cancer through a modular protein design platform.

T-Therapeutics

The company develops T cell receptor therapeutics and bispecific engagers for patients with cancer and autoimmune diseases.

Caldera Therapeutics

This clinical-stage biotechnology company develops bispecific antibodies to treat patients with inflammatory bowel disease and other immune-mediated conditions.

Pionyr Immunotherapeutics

This company develops antibody therapeutics that modify the tumor microenvironment to treat cancer patients.

NovalGen

NovalGen develops multi-specific antibody therapies and self-regulating immunotherapies for patients with oncology, autoimmune, haematological, and metabolic disorders.